新聞與行事曆

HEALTHCARE U.S. Food and Drug Administration Add Topic Eli Lilly's diabetes drug Mounjaro gets approval for a new use Ken Alltucker USA TODAY Aug. 28, 2026, 1:40 p.m. ET Hear this story The Food and Drug Administration approved Eli Lilly's diabetes drug Mounjaro to cut down the risk of heart attack or stroke in high-risk adults with Type 2 diabetes. The approval gives consumers another option when seeking a GLP-1 medication to lower heart-related health risk. In 2024, the FDA approved Novo Nordisk's anti-obesity drug, Wegovy, to lower the risk of cardiovascular events such as heart attack and…

Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial Fatima Gulzar Sat, August 29, 2026 at 2:16 AM GMT+10 4 min read MRNA MRK On August 19, 2026, Moderna, Inc. (NASDAQ: MRNA ) and Merck & Co., Inc. (NYSE: MRK ) said their personalized melanoma vaccine, intismeran, combined with Merck's Keytruda, met its goals in a Phase 3 trial of 1,137 patients. It reduced the risk of cancer recurrence and spread compared with Keytruda alone, Reuters reported. It is the first positive late-stage trial result for an mRNA cancer vaccine. Merck's Jane Healy called the result a "clinically meaningf…

Nvidia has reportedly agreed to buy popular AI library Hugging Face for $12.9 billion. The deal is partly a hedge against an emerging threat: AI companies which consume enormous quantities of Nvidia hardware are increasingly developing chips of their own. In a future where AI becomes centralized in a small group of players with their own chips, those companies could demand lower prices from Nvidia or bypass it altogether. Hugging Face, an online hub where developers share open AI models and datasets, gives Nvidia a stake in an alternative future, where downloadable AI models allow startups and…